IFI30‐mediated EGFR/AKT/GSK3β/β‐catenin signaling not only promotes the epithelial–mesenchymal transition‐like phenotype by upregulating the expression of Slug, but also subsequently enhanced invasion and chemoresistance of glioma cells. This evidence concerns the gene SNAI2 and glioma.